Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Interventional
×
pegilodecakin
×
Clear all
Filters
3
NCT02009449
2024-11-15
IVY
Eli Lilly and Company
Phase 1
Completed
353 enrolled
NCT02923921
2020-10-19
Sequoia
Eli Lilly and Company
Phase 3
Completed
567 enrolled
17 charts